National Institute of Health Clinical Center

Bethesda, Maryland 20892

1 studies enrolling now · 1 studies all time

What they study most

HER2-negative Breast Cancer, Metaplastic Breast Carcinoma, Metastatic Breast Cancer, TNBC - Triple-Negative Breast Cancer

Studies at this site

• Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC) — Recruiting now